UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
Date of
Report (Date of earliest event
reported): November 6, 2017
|
TONGJI HEALTHCARE GROUP,
INC.
(Exact
name of registrant as specified in its charter)
|
Nevada
|
|
333-140645
|
|
None
|
|
(State
or other
jurisdiction
of incorporation)
|
|
(Commission
File
Number)
|
|
(I.R.S.
Employer
Identification
No.)
|
|
No. 5 Beiji Road
Nanning, Guangxi, People’s Republic of China
|
||||
|
(Address
of principal executive offices) (zip code)
|
|
86-771-2020000
|
||||
|
(Registrant’s
telephone number, including area code)
|
|
Not
Applicable.
|
||||
|
(Former
name or former address, if changed since last report.)
|
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
|
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
|
|
|
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
|
|
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
|
1
Item
5.02
Departure
of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers.
On
November 6, 2017, Mr. Eric Zhang notified Tongji Healthcare Group,
Inc. (the “Company”) that he intends to resign as Chief
Financial Officer of the Company for personal reasons, effective
November 15, 2017. Mr.
Zhang’s resignation is not in connection with any known
disagreement with the Company on any matter.
On
November 8, 2017, the Board appointed Mr. Yunhui Yu , the
Company’s President and Chief Executive Officer as its
interim Chief Financial Officer , effective November 15, 2017. Mr.
Yu will serve as interim Chief Financial Officer until a successor
is named. The Company is in the process of conducting a search for
Chief Financial Officer and will name that successor at the
completion of the search. Mr. Yu shall not receive any additional
consideration for his services as interim Chief Financial
Officer.
Mr. Yu
is our founder and has been our Chief Executive Officer, President
and one of our directors since October 2003. Since October 1999 Mr.
Yu has also been the Chief Executive Officer and a director of
Guangxi Tongji Medicine Co., Ltd., an affiliated company which
operates pharmacies in China. Mr. Yu received his bachelor's degree
in medicine from the First Military Medical University of the
People's Liberation Army of China in August 1984. Mr. Yu holds a
license as a physician from the Chinese Ministry of
Health.
There
are no family relationships between Mr. Yu and any director or
executive officer of the Company, or any person nominated or chosen
by the Company to become a director or executive officer. There are
no arrangements or understandings between Mr. Yu and any other
persons pursuant to which he was selected as interim Chief
Financial Officer.
2
SIGNATURE
Pursuant to the
requirements of the Securities Exchange Act of 1934, the Registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
Date:
November 8, 2017
|
|
TONGJI
HEALTHCARE GROUP, INC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By: /s/
Yunhui Yu
|
|
|
|
Yunhui
Yu
|
|
|
|
President
and Chief Executive Officer
|
3